Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American…

Overview of attention for article published in Journal of Clinical Oncology, May 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 9 news outlets
blogs: 1 blog
twitter: 23 X users

patent: 1 patent
googleplus: 1 Google+ user
guideline: 2 clinical guideline sources

Readers on

mendeley: 114 Mendeley

So far, Altmetric has seen 9 news stories from 9 outlets.

The Cell’s Software: Fixing Rogue Epigenetics To Combat Cancer

Technology Networks, 14 Nov 2025

There are thousands of different cell types in our body. Whether their function is to carry oxygen, conduct nerve signals or…

New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes

2 News, 07 Dec 2017

Information contained on this page is provided by an independent third-party content provider.

New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes

KTRE, 07 Dec 2017

Information contained on this page is provided by an independent third-party content provider.

New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes

Ticker Tech, 07 Dec 2017

CARLSBAD, Calif., Dec. 7, 2017 /PRNewswire/ -- Clinical researchers interested in studying driver mutations suspected in…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 5 additional news stories.